| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.300 | Biomarker | phenotype | CTD_human | Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis. | 28899902 | 2017 | ||||
|
0.300 | Therapeutic | phenotype | CTD_human | Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis. | 28899902 | 2017 | ||||
|
0.300 | Therapeutic | phenotype | CTD_human | Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits. | 25619500 | 2015 | ||||
|
0.300 | Biomarker | phenotype | CTD_human | Bisphenol A exposure induces metabolic disorders and enhances atherosclerosis in hyperlipidemic rabbits. | 25619500 | 2015 | ||||
|
0.300 | Biomarker | phenotype | CTD_human | Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins. | 22153697 | 2012 | ||||
|
0.300 | Therapeutic | phenotype | CTD_human | Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins. | 22153697 | 2012 | ||||
|
0.300 | Biomarker | phenotype | CTD_human | Mangifera indica L. extract (Vimang) and its main polyphenol mangiferin prevent mitochondrial oxidative stress in atherosclerosis-prone hypercholesterolemic mouse. | 18450471 | 2008 | ||||
|
0.300 | Therapeutic | phenotype | CTD_human | Mangifera indica L. extract (Vimang) and its main polyphenol mangiferin prevent mitochondrial oxidative stress in atherosclerosis-prone hypercholesterolemic mouse. | 18450471 | 2008 | ||||
|
0.300 | Therapeutic | phenotype | CTD_human | Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. | 11947894 | 2002 | ||||
|
0.300 | Biomarker | phenotype | CTD_human | Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. | 11947894 | 2002 |